MCOX [Mecox Lane] 6-K: (Original Filing)

[Mecox Lane Limited Announces Fourth Quarter and Full Year 201 4 Results Fourth-quarter and full-year net revenues increase 19.5% and 16.4% year over year SHANGHAI, March 9, 2015 — Mecox Lane Limited (“Mecox Lane” or the “Company”) (NASDAQ: MCOX), a multi-brand and multi-channel retailer of health, beauty and lifestyle products in China , today announced its unaudited financial results for] [MECOX LANE LIMITED Room 302, Qilai Building, No. 889, Yishan Road Shanghai 200233 People’s Republic of China (86-21) 3108 1111 Form 20-F x Form 40-F o o o Yes o No x 82- N/A]

By | 2016-03-18T15:26:08+00:00 March 10th, 2015|Categories: Chinese Stocks, MCOX, SEC Original|Tags: , , , , , |0 Comments
Read More

HSOL [Hanwha Q CELLS] SC TO-I: (Original Filing)

[] [FUNDAMENTAL CHANGE PURCHASE NOTICE TO NOTEHOLDERS OF 3.5% CONVERTIBLE SENIOR NOTES DUE 2018 ISSUED BY HANWHA Q CELLS CO., LTD. (FORMERLY KNOWN AS HANWHA SOLARONE CO., LTD. OR SOLARFUN POWER HOLDINGS CO., LTD.) CUSIP NUMBERS: 83415UAA6 / 83415UAB4 “Indenture” “Company” “Trustee” “Paying Agent” Fundamental Change Purchase Notice “Notes” Reference is made to the Indenture dated as of January 29, 2008]

By | 2016-04-03T00:46:19+00:00 March 9th, 2015|Categories: Chinese Stocks, HSOL, SEC Original|Tags: , , , , , |0 Comments
Read More

HSOL [Hanwha Q CELLS] 6-K: (Original Filing)

[Press Release Hanwha Q CELLS Supplies 75 MW of Modules to juwi solar Supply deal to include modules assembled in South Korea Irvine, Calif. – March 9, 2015 “juwi chose Hanwha Q CELLS’ module because of its high efficiency German engineered cells,” said Forrest Collins, director of technology of juwi solar. “In addition, Hanwha Q CELLS has been classified as] [Hanwha Q CELLS Co., Ltd. Seong Woo Nam Chairman and CEO 6-K 1 d889658d6k.htm FORM 6-K]

By | 2016-04-03T00:49:10+00:00 March 9th, 2015|Categories: Chinese Stocks, HSOL, SEC Original|Tags: , , , , , |0 Comments
Read More

DATE [JIAYUAN.COM INTERNATIONAL] 6-K: (Original Filing)

[Jiayuan Announces Fourth Quarter and Full Year 2014 Financial Results BEIJING, China, March 5, 2015 — Jiayuan.com International Ltd. (“Jiayuan”) (NASDAQ: DATE), operator of the largest online dating platform in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2014. Fourth Quarter 2014 Highlights 1 · Net revenues for the fourth quarter] [001-35157 JIAYUAN.COM INTERNATIONAL LTD. F/15, Anhua Development Building No. 35 Anding Road Chaoyang District, Beijing The People’s Republic of China (8610) 6113-6312 Form 20-F x Form 40-F ¨ o o Yes o No x O 2]

By | 2016-03-27T17:15:03+00:00 March 9th, 2015|Categories: Chinese Stocks, DATE, SEC Original|Tags: , , , , , |0 Comments
Read More

KANG [iKang Healthcare] 6-K: (Original Filing)

[Press Release iKang Acquires 70% Share of WA Health Care to Offer Premium Medical Service to High-end Market in China BEIJING, March 6, 2015 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), today announced that it has acquired a 70% equity interest in WA Centers HK Limited (“WA Health Care”). Established in 2010, WA Health] [FORM 6-K IKANG HEALTHCARE GROUP, INC. B-6F, Shimao Tower 92A Jianguo Road Chaoyang District, Beijing 100022 People’s Republic of China Form 20-F x Form 40-F o o o IKANG HEALTHCARE GROUP, INC.]

By | 2016-03-22T16:10:04+00:00 March 9th, 2015|Categories: Chinese Stocks, KANG, SEC Original|Tags: , , , , , |0 Comments
Read More

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2014 Fourth Quarter and Full Year Results SHENZHEN, China, March 9, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2014. Highlights for Fourth Quarter and Full Year 2014 - Full] []

By | 2016-03-29T00:12:42+00:00 March 9th, 2015|Categories: Chinese Stocks, MR, SEC Original|Tags: , , , , , |0 Comments
Read More
Skip to toolbar